EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients

Jane Koo iD, John Huber iD, Priscila Badia iD, Chloe Dunseath, Gabby O'Connor, Stella M Davies iD, Christopher E Dandoy iD

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.31336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Jane Koo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Invasive Fungal Infections, Transplantation, Autologous. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pediatric and young adult patients undergoing autologous hematopoietic stem cell transplant (auto‐HSCT) face a crucial, yet understudied, risk of invasive fungal infections (IFI), especially compared to allogeneic transplants. This gap underscores the need for research in pediatric patients undergoing auto‐HSCT. Our objective was to evaluate the incidence of IFI in pediatric and young adult patients during the first year after auto‐HSCT. Materials and methods We conducted a single‐center retrospective analysis of 150 pediatric and young adult auto‐HSCT patients who underwent transplant from January 2013 to January 2023. We focused on IFI incidence within the first‐year post transplant, using the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria for IFI identification.

Results

Among the 150 patients analyzed, with 240 unique transplant episodes, the primary indication was neuroblastoma (37.3%), and micafungin was extensively used for prophylaxis (82.7%). There was an absence of IFI from yeast and mold species, suggesting a low IFI risk in this cohort. The incidence of IFI in pediatric auto‐HSCT recipients receiving micafungin primary antifungal prophylaxis is rare.

Conclusions

The findings advocate for further research to refine prophylaxis guidelines and highlight the need for individualized risk assessment to optimize post‐transplant care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationInvasive Fungal InfectionsTransplantation, AutologousHumansMaleRetrospective StudiesFemaleAdolescentChildYoung AdultAdultChild, PreschoolIncidenceAntifungal AgentsFollow-Up StudiesInfantPrognosis

Stichwörter der Autor:innen

autologous stem cell transplantfungal infectionsinvasive fungal infectionspediatric hematopoietic stem cell transplant

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.

ORCID-Profile: Jane Koo, John Huber, Priscila Badia, Stella M Davies, Christopher E Dandoy

Zitieren

APA

Koo, J., Huber, J., Badia, P., Dunseath, C., O'Connor, G., Davies, S. M., & Dandoy, C. E. (2024). Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31336

Vancouver

Koo J, Huber J, Badia P, Dunseath C, O'Connor G, Davies SM, et al. Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31336

BibTeX
@article{Koo2024,
  author = {Koo, Jane and Huber, John and Badia, Priscila and Dunseath, Chloe and O'Connor, Gabby and Davies, Stella M and Dandoy, Christopher E},
  title = {Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.31336}
}
Kostenlos starten →